Evonik Cuts 3,200 Jobs, Exits Polyester in Cost-Cutting Push
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Specialty chemicals group Evonik announced on 18 June 2026 that it will cut 3,200 jobs and exit its entire polyester business. The move is part of a newly launched cost-reduction program targeting 800 million euros in annual savings by 2028. The job cuts represent approximately 7% of Evonik's global workforce.
Evonik's restructuring follows a prolonged period of margin pressure across the European chemical sector. The last major sector-wide job cuts of similar scale occurred at BASF in late 2023, when it announced 2,600 position reductions. That move was a response to high European energy costs and weak global demand.
The current macro backdrop features persistently high energy prices in Europe and muted industrial activity. The Eurozone Manufacturing PMI has remained below the 50.0 expansion threshold for over 24 consecutive months. Global polyester markets face a structural oversupply, particularly from new capacity expansions in China and Southeast Asia.
The immediate catalyst for Evonik's decisive action is its 2025 annual report, which highlighted a 15% year-on-year decline in EBITDA from its performance materials segment. This segment houses the struggling polyester and polyamide operations. Management cited a failure to achieve previous overlap targets from integrated production as a key trigger. Strategic reviews initiated in Q1 2026 concluded that exiting the capital-intensive, low-margin polyester chain was necessary to free capital for higher-margin specialty businesses.
The restructuring plan is quantified across several key metrics. The 3,200 job reductions will occur between 2026 and 2028, with two-thirds of the cuts in Germany. The company expects to incur one-time restructuring costs of approximately 500 million euros. Evonik aims to achieve annual savings of 800 million euros once the program is fully implemented.
The division being exited, Performance Materials, generated 2.1 billion euros in sales in 2025 but contributed only 7% to group EBITDA. The segment's EBITDA margin of 6% was less than half the group's target of 15%. A sale of the polyester assets is expected to generate proceeds of 1.5 to felt 2.0 billion euros, which will be used to reduce net debt.
This strategic shift follows a period of underperformance relative to peers. Evonik's stock declined 22% over the past five years, while the STOXX Europe 600 Chemicals Index fell only 8% over the same period. The company's current market capitalization of around 14 billion euros lags behind its peak of over 25 billion euros in 2018.
| Metric | Before Restructuring (2025) | Target (2028) |
|---|---|---|
| Group EBITDA Margin | 12% | 15%+ |
| Net Financial Debt / EBITDA | 3.2x | <2.5x |
| Annual Cost Base | N/A | -800M EUR |
The immediate market beneficiaries are likely to be other European specialty chemical producers like Lanzess (LXS) and Wacker Chemie (WCH). These firms compete with Evonik in higher-margin silicones and functional polymers but are not burdened by large, commoditized polyester operations. Investors may re-rate these peers as Evonik's exit reduces sector-wide overcapacity and refocuses the investment narrative on specialty margins.
The primary losers are companies deeply integrated into the polyester value chain, particularly upstream suppliers of purified terephthalic acid (PTA) and monoethylene glycol (MEG). This includes Indorama Ventures and Reliance Industries, though their global scale may mitigate localized European demand impacts. European engineering firms that service polyester production lines may see a reduction in orders.
One counter-argument is that the 500 million euro restructuring charge and the multi-year implementation horizon could pressure near-term earnings. Selling the assets in a buyer's market may also result in lower proceeds than the 1.5-2.0 billion euro target. Positioning data from recent weeks shows short interest in Evonik had climbed to a 12-month high, suggesting the market anticipated a significant strategic shift. The announcement may trigger a short-covering rally, but sustained re-rating depends on executing the asset sales at favorable terms.
Investors should monitor the official launch of the sale process for the polyester assets, expected in Q3 2026. The identity of potential buyers will signal the health of the broader industry. A sale to a financial sponsor versus a strategic competitor like Indorama would carry different implications for future market discipline.
Key financial levels to watch are Evonik's quarterly EBITDA margin reports. A sustained move above 13% would signal the restructuring is gaining traction. Conversely, a drop below 11% would indicate underlying operational challenges persist. The company's Q2 2026 earnings report on 7 August 2026 will provide the first detailed guidance on the program's initial phase.
The wider sector impact will be tested during the Q2 2026 earnings season for European chemicals in late July. Commentary from BASF and Covestro on their own cost structures and portfolio reviews will either validate or contradict Evonik's aggressive path.
Evonik has indicated its commitment to maintaining a stable dividend policy throughout the restructuring. The planned asset sales are intended to strengthen the balance sheet, which supports dividend sustainability. However, the 500 million euro in upfront restructuring costs may pressure free cash flow in 2026 and 2027, potentially limiting dividend growth until the savings program matures. Investors should watch for explicit guidance on payout ratios in upcoming earnings calls.
The scale of Evonik's cuts is significant for a specialty chemical firm. It exceeds the 2,600 job cuts announced by BASF in 2023 but is smaller than the 5,000+ reductions undertaken by DowDuPont during its 2019 split. The 7% workforce reduction is more aggressive than the 3-5% typical of recent European corporate cost programs, reflecting the severe margin pressure in commodity-linked segments and the high cost base in Germany.
Major chemical producers have been scaling back in polyester intermediates for over a decade due to chronic oversupply and low returns. Shell sold its last PTA assets in 2019. BP exited the purified terephthalic acid business in the mid-2010s. Evonik's move continues this trend of Western chemical majors retreating from petrochemical intermediates where they lack a cost advantage against integrated Middle Eastern and Asian producers, focusing instead on differentiated, patent-protected products.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.